Patent: 8,337,811
✉ Email this page to a colleague
Summary for Patent: 8,337,811
Title: | Pharmaceutical composition of nanoparticles |
Abstract: | The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, poly-glutamic acid, and a bioactive agent for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability for oral drug delivery. |
Inventor(s): | Sung; Hsing-Wen (Hsinchu, TW), Sonaje; Kiran (Hsinchu, TW), Nguyen; Ho-Ngoc (Hsinchu, TW), Chuang; Er-Yuan (Hsinchu, TW), Tu; Hosheng (Newport Beach, CA) |
Assignee: | GP Medical, Inc. (Newport Beach, CA) National Tsing Hua University (Hsinchu, TW) |
Application Number: | 13/418,299 |
Patent Claims: | see list of patent claims |
Details for Patent 8,337,811
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | 06/01/1989 | ⤷ Try a Trial | 2025-01-04 |
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | ⤷ Try a Trial | 2025-01-04 | |
Amgen, Inc. | PROCRIT | epoetin alfa | Injection | 103234 | ⤷ Try a Trial | 2025-01-04 | |
Amgen, Inc. | ARANESP | darbepoetin alpha | Injection | 103951 | 09/17/2001 | ⤷ Try a Trial | 2025-01-04 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |